EUGIA PHARMA SPECLTS FDA Approval ANDA 215123

ANDA 215123

EUGIA PHARMA SPECLTS

FDA Drug Application

Application #215123

Application Sponsors

ANDA 215123EUGIA PHARMA SPECLTS

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002

Application Products

002CAPSULE;ORALEQ 150MG BASE0NINTEDANIBNINTEDANIB

FDA Submissions

UNKNOWN; ORIG1TA2022-05-12STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

EUGIA PHARMA SPECLTS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215123
            [companyName] => EUGIA PHARMA SPECLTS
            [docInserts] => ["",""]
            [products] => [{"drugName":"NINTEDANIB","activeIngredients":"NINTEDANIB","strength":"EQ 100MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"NINTEDANIB","activeIngredients":"NINTEDANIB","strength":"EQ 150MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/12\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-05-12
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.